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The overexpression of defined transcription factors in somatic cells results in their reprogramming into induced pluripotent stem (iPS) cells [1] [2] [3] . The extremely low efficiency and slow kinetics of in vitro reprogramming suggest that further rare events are required to generate iPS cells. The nature and identity of these events, however, remain elusive. We noticed that the reprogramming potential of primary murine fibroblasts into iPS cells decreases after serial passaging and the concomitant onset of senescence. Consistent with the notion that loss of replicative potential provides a barrier for reprogramming, here we show that cells with low endogenous p19
Arf (encoded by the Ink4a/Arf locus, also known as Cdkn2a locus) protein levels and immortal fibroblasts deficient in components of the Arf-Trp53 pathway yield iPS cell colonies with up to threefold faster kinetics and at a significantly higher efficiency than wild-type cells, endowing almost every somatic cell with the potential to form iPS cells. Notably, the acute genetic ablation of Trp53 (also known as p53) in cellular subpopulations that normally fail to reprogram rescues their ability to produce iPS cells. Our results show that the acquisition of immortality is a crucial and rate-limiting step towards the establishment of a pluripotent state in somatic cells and underscore the similarities between induced pluripotency and tumorigenesis.
The possibility to generate patient-specific pluripotent cells may enable the study and treatment of several degenerative diseases and therefore has enormous therapeutic potential. A major limitation of inducing pluripotency, however, is its low efficiency, which ranges between 0.01% and 0.2% when using direct viral infection of adult cells with vectors expressing the four reprogramming factors-Oct4 (also known as Pou5f1), Sox2, Klf4 and c-Myc 2,4-6 -and reaches up to ,5% when using optimized 'secondary systems' [7] [8] [9] . Secondary systems are based on somatic cells that already carry all four reprogramming transgenes in their genome under the control of doxycycline-inducible elements, thus enabling homogeneous factor expression (Supplementary Fig. 1 ). The low efficiency of reprogramming secondary cells suggests that other molecular events are required that restrict the conversion of somatic cells into iPS cells 1 . Identifying these restrictions is critical for understanding the mechanisms of induced pluripotency as well as for its potential clinical applications.
We noticed that secondary murine embryonic fibroblasts (MEFs) at early passages generate iPS cells more efficiently than MEFs at later passages, consistent with the notion that a high replicative potential of somatic cells is critical for successful reprogramming into iPS cells (Fig. 1a, top row) . The accumulation of b-galactosidase-positive senescent cells in late passage cultures further suggests that molecular changes associated with cellular senescence provide a roadblock for the conversion of somatic cells into iPS cells (Fig. 1a, bottom row) . The loss of replicative potential is often the consequence of culture-induced upregulation of the cell-cycle-dependent kinase inhibitors p16 Ink4a , p19
Arf (which are encoded by alternative reading frames of the Ink4a/Arf locus), p21
Cip1 (Cdkn1a), as well as activation of Trp53 (ref. 10) . Indeed, we observed a progressive upregulation of Ink4a, Arf and Cip1 transcript levels in serially passaged MEFs (Fig. 1b) . Growth of MEFs in low oxygen (4%) can counteract culture-induced upregulation of p16
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. We detected a threefold increase in reprogramming efficiency in secondary MEFs cultured in low oxygen (Fig. 1d, e) , in agreement with the notion that p16
Ink4a and activated Trp53 inhibit reprogramming.
To test directly whether the expression status of the Ink4a/Arf locus in the starting cell population has an influence on reprogramming, we analysed cells derived from an Arf-green fluorescent protein (GFP) knock-in reporter mouse 12 . Arf-GFP MEFs at passage 3 contained a population of Arf-GFP high and Arf-GFP low cells, consistent with previous observations 12 (Fig. 1f) . Interestingly, fluorescence-activated cell sorting (FACS)-purified Arf-GFP low MEFs yielded iPS cell colonies twice as efficiently as Arf-GFP high MEFs, indicating that reduced Arf levels in the starting cell population are beneficial for reprogramming (Fig. 1g, h) .
Notably, Arf-GFP expression was undetectable and endogenous Ink4a and Arf transcript levels were downregulated in established iPS cells ( Fig. 2a and Supplementary Fig. 2a ), further indicating that inactivation of this key senescence pathway by the reprogramming factors may be critical for the acquisition of pluripotency. In agreement, expression of the four reprogramming factors for 6 days resulted in efficient downregulation of the Arf-GFP allele (Fig. 2a) . However, no single reprogramming factor alone was sufficient to silence Arf-GFP expression (Fig. 2a) , suggesting that the synergistic action of at least two of the factors is required to inhibit Arf transcription.
To examine how silencing of the Ink4a/Arf locus correlates with other markers that change during reprogramming, we followed the expression of Arf-GFP in intermediate cell populations previously identified by surface markers 13, 14 . Notably, Arf expression was downregulated specifically in the Thy1 2 and SSEA1 1 fractions, which are enriched for cells poised to become iPS cells, but not in the Thy1 1 fraction, which fails to give rise to iPS cells (Fig. 2b) . Ink4a RNA and protein levels followed a similar trend as the Arf-GFP expression during reprogramming ( Supplementary Fig. 3 ). Of note, SSEA1
1 Arf-GFP low cells had a threefold higher reprogramming potential than SSEA1 1 Arf-GFP high cells, indicating that low Arf expression is a useful prospective marker to further enrich for intermediate cells poised to become iPS cells (Fig. 2c, d ). Together, these results show that downregulation of the Ink4a/Arf locus correlates well with, and further refines previously identified subpopulations of cells undergoing reprogramming.
Using a published PCR-based assay 15 , we found that iPS cells and ES cells, in contrast to MEFs, show Ink4a/Arf promoter methylation, consistent with stable transcriptional silencing of Ink4a/Arf in pluripotent cells ( Supplementary Fig. 2b ). However, the downregulation of Arf-GFP expression at day 6 of reprogramming as seen by FACS (Fig. 2b) was not yet accompanied by detectable promoter methylation, suggesting that stable silencing of the Ink4a/Arf locus is a late event during reprogramming that requires further molecular changes. In agreement with a transient decrease in Arf expression, the withdrawal of doxycycline from day 6 cultures resulted in the rapid re-appearance of Arf-GFP expression and the failure to recover stable iPS cell colonies (Fig. 2b and data not shown). Promoter methylation first became detectable at day 9 of reprogramming in the SSEA1 1 fraction ( Supplementary Fig. 2b ), which contains most stably reprogrammed cells 13 . This observation indicates that the stable silencing of the Ink4a/Arf locus is achieved by epigenetic modifications and occurs specifically in late intermediate cells that are poised to become iPS cells.
Because genetic deletion of the entire Ink4a/Arf locus in fibroblasts results in their immortalization 16 , we wondered whether immortalized somatic cells are more amenable to reprogramming than primary cells. We first assessed the reprogramming potential of a spontaneously immortalized melanocyte line 17 (designated 'Melan A'). Melan A cells gave rise to iPS cells four times more efficiently than primary melanocytes, yielding efficiencies close to 1% (Fig. 3a and Supplementary  Fig. 4a-d) . Injection of these iPS cells into severe combined immunodeficient (SCID) mice gave rise to well-differentiated teratomas, and introduction into blastocysts yielded chimaeric mice that showed contribution to different tissues (Fig. 3b, c and Supplementary Fig. 4e ). These results document that an established cell line remains permissive for reprogramming into a pluripotent state. Spontaneous immortalization of cultured cells is usually accompanied by mutations of components of the Arf-Trp53 pathway 18 . Indeed, western blot analysis showed the absence of p16
Ink4a protein in Melan A cells ( Supplementary Fig. 4f ) even though sequence analysis of the Ink4a and Arf exons did not reveal any mutations (data not shown).
To assess more accurately reprogramming frequencies of immortalized versus primary melanocytes, we established secondary cells by in vitro differentiation of iPS cells 7, 8 ( Supplementary Figs 1 and 5a ). Secondary cells obtained from primary melanocytes converted into iPS cells at an average efficiency of 1.5%, consistent with previous observations [7] [8] [9] 19 (Fig. 3d, clones 1-3) . Remarkably, however, Melan A-derived secondary cells gave rise to iPS cells at efficiencies of up to ,65%, indicating that immortalization endows almost two in three cells with the potential to form iPS cells (Fig. 3d , clones 57-61 and Supplementary Fig. 5b ). Moreover, single-cell sorting of one subclone (clone 59.3) generated iPS cells at 100% efficiency, demonstrating that most, if not all, of the cells are endowed with the potential to give rise to pluripotent colonies (Fig. 3e) . Secondary MEFs obtained from Melan A-iPS cells at embryonic day (E) 14.5 gave rise to iPS cell colonies at an efficiency of ,40%, which is comparable to in vitro-derived secondary cells (Fig. 3d, clones M4 and M7) .
We next tested whether deletion of Trp53 or Ink4a/Arf in fibroblasts mimics the phenotype of spontaneously immortalized cells. Indeed, we observed a 30-40-fold increase in the number of iPS cell colonies in Trp53, compound Ink4a/Arf and single Arf mutant cells compared with wild-type control cells, demonstrating that inactivation of these pathways is probably responsible for the increased reprogramming efficiencies of spontaneously immortalized cells (Fig. 3f , Supplementary Fig. 6 and Supplementary Table 1 ). Moreover, Trp53 2/2 iPS-cell-derived E14.5 secondary MEFs gave rise to iPS cell colonies at an efficiency of ,80%, similar to results obtained with spontaneously immortalized cells (Fig. 3g) . Collectively, these observations provide strong functional evidence that the inactivation of key pathways controlling replicative potential and senescence substantially enhance the reprogramming potential of somatic cells into iPS cells.
To exclude the possibility that an altered growth rate of immortal cells rather than their long-term proliferation potential influences their increased reprogramming potential, we compared the iPS cell formation efficiencies of Trp53 2/2 and wild-type MEFs grown under low (0.5% FBS) and high (15% FBS) serum conditions. Trp53-deficient MEFs cultured in low serum exhibited a significantly reduced growth rate compared with MEFs cultured in high serum ( Supplementary  Fig. 7a ). Despite this growth disadvantage, Trp53-mutant cells gave rise to iPS cells more efficiently than wild-type MEFs, suggesting that the long-term proliferation potential of immortal cells is responsible for their enhanced reprogramming potential ( Supplementary Fig. 7b, c) .
Given that the acquisition of immortality by downregulation of Arf or Trp53 seems to eliminate a roadblock during the reprogramming of somatic cells into iPS cells, inactivation of these pathways might also affect the kinetics of reprogramming. Indeed, although wild-type cells required 8 days of transgene expression to produce stable iPS cells, which is consistent with a previous report 13 , Trp53 and Ink4a/ Arf mutant cells gave rise to iPS cell colonies after only 3 and 4 days of transgene expression, respectively, demonstrating that the acquisition of cellular immortality is not only an efficiency-limiting but also a rate-limiting step during induced pluripotency (Fig. 3h) .
Surprisingly, we failed to detect a correlation between the relative numbers of Thy1 Fig. 8 ). This suggests that immortal cells undergoing reprogramming pass through the same roadblocks as control cells but that immortality endows those cells that otherwise fail to reprogram with the potential to form iPS cells. To test this hypothesis further, we plated FACS-purified Thy1
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2 and SSEA1 1 cells isolated from wild-type or Trp53-deficient secondary cells on feeders in the presence or absence of doxycycline (Fig. 4a) . In wild-type cells, iPS cells appeared predominantly from the SSEA1 1 population at all time points and to a lesser degree from the Thy1 2 and Thy1 1 fractions in the continuous presence of doxycycline (Fig. 4a, left) . However, when doxycycline was withdrawn after the sorting of these populations, only the SSEA1 1 fraction at day 9 gave rise to stable iPS cells, consistent with previous observations 13, 14 ( Fig. 4a, right) . This result is in accordance with the earlier finding that the methylation of the Ink4a/Arf locus becomes detectable specifically in the SSEA1
1 population in wild-type cells (Supplementary Fig. 2b) . In contrast, Trp53-deficient secondary cells continuously treated with doxycycline gave rise to iPS cells at high efficiency and regardless of the Thy1 and SSEA1 expression status (Fig. 4a, left) . Moreover, when doxycycline treatment was discontinued after sorting, iPS cell colonies emerged from Thy1 SSEA1 ) and eventually the acquisition of immortality (for example, silencing of Arf). The low efficiency of the process is probably due to the capacity of rare cells to overcome these roadblocks. In immortal fibroblasts, however, almost every cell is endowed with the potential to produce iPS cells. Moreover, cells that have already encountered a roadblock can be rescued by acute inactivation of Trp53 (indicated by dashed black lines). Red bar illustrates the transition point between the somatic (blue) and the pluripotent (yellow) state. cells as early as 3 days after induction of transgenes. These findings confirm that reprogramming kinetics are up to three times faster in immortal cells than primary cells, and demonstrate that Trp53 deficiency confers reprogramming potential to cells that normally fail to form iPS cells.
Because continuous Trp53 deficiency in MEFs may select for genomic aberrations that favour reprogramming into iPS cells, we acutely inhibited Trp53 expression by infecting secondary wild-type cells with a lentiviral construct expressing a short hairpin RNA (shRNA) against Trp53 (Trp53 shRNA) 20 . We found that MEFs treated with Trp53 shRNA at any time point during reprogramming gave rise to iPS cell colonies at higher efficiency than control cells (Fig. 4b) . Furthermore, infection of Thy1 1 and Thy1 2 cells with Trp53 shRNA yielded iPS cells at similar efficiencies as the SSEA1 1 population, demonstrating that the acute inactivation of Trp53 is sufficient to confer the ability to undergo reprogramming on cells that would otherwise fail to form iPS cells (Fig. 4c) . Likewise, the treatment of senescent cultures, which appear refractory to reprogramming, with Trp53 shRNA rescued their ability to produce iPS cells (Supplementary Fig. 9) . Notably, we demonstrate a continuous requirement for the absence of Trp53 to elicit an enhanced effect on reprogramming using a Cre-reactivatable allele of Trp53 (Supplementary Fig. 10 ).
Furthermore, we sought to determine whether human immortalized cells are equally amenable to reprogramming as murine cells. To this end, we compared the reprograming abilities of primary and TERT-immortalized human keratinocyte cell lines, which show comparable growth rates but obvious differences in their long-term proliferation potential 21 . Indeed, TERT-immortalized keratinocyte lines gave rise to iPS-cell-like colonies ,20 times more efficiently than early passage cultures of the primary keratinocyte line, from which they were derived (strain N) 21 , indicating that overcoming replicative senescence may be critical during the reprogramming of both murine and human somatic cells into iPS cells (Supplementary Fig. 11 ).
Our results indicate that the acquisition of immortality by epigenetic silencing of the Ink4a/Arf locus provides a bottleneck for the conversion of somatic cells into iPS cells, thus contributing to the low efficiency and delayed kinetics of in vitro reprogramming. After immortalization of fibroblasts, however, almost every somatic cell (or its clonal offspring) is endowed with the potential to generate iPS cells (Fig. 4d) . Our findings are consistent with previous reports showing a more subtle effect of genetically interfering with immortalization pathways on iPS cell formation efficiency in human cells 22, 23 . Because Trp53 and p19 Arf are guardians of chromosomal stability, however, their manipulation in a therapeutic setting should be approached with caution. Primary cell populations with low endogenous levels of active Trp53 or p16
Ink4a and p19
Arf (refs 24-26) or cells with a high endogenous proliferative potential, such as somatic stem and progenitor cells 27 , might provide an alternative and safer source for producing iPS cells at high efficiency.
METHODS SUMMARY
To generate iPS cells, primary and immortalized cell populations were infected with lentiviral vectors expressing Oct4, Sox2, Klf4 and c-Myc from a polycistronic construct under the control of a doxycycline-inducible promoter, together with a lentivirus constitutively expressing the M2 reverse tetracycline transactivator (M2-rtTA). Secondary cells were derived either by in vitro differentiation of iPS cells or after blastocyst injection and isolation of fibroblasts from chimaeras. The developmental potential of iPS cells was assessed by teratoma formation after subcutaneous injection into immunocompromised mice and by chimaera formation after blastocyst injection. Intermediate cell populations were isolated by flow cytometry.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
